Swiftmerge (IVCP) Announces LOI with HDL Therapeutics
by Nicholas Alan Clayton on 2023-04-24 at 2:41pm

Swiftmerge Acquisition Corp. (NASDAQ:IVCP) announced this afternoon that it has signed a non-binding letter of intent to combine with commercial-stage biotech company HDL.

The parties’ press release did not include a proposed valuation for the deal, but Swiftmerge currently has about $228 million in trust and about two months left before its June 17 transaction deadline.  The SPAC aims to advance the LOI to a definitive agreement later this quarter.

Like the target of today’s other SPAC transaction, HDL has developed and commercialized a medical device to treat sufferers of heart disease.

Its PDS-2 system has been approved to treat homozygous familial hypercholesterolemia, a disorder that renders the body less capable of removing harmful cholesterol and more susceptible to heart attacks at an early age.

The PDS-2 uses patients’ own plasma to create natural lipoproteins that can reduce plaque blockages and lower overall risk levels. HDL believes this same approach could be used to treat other disorders of the heart, kidneys, arteries and even neurodegenerative diseases like Alzheimer’s. But, such applications have not yet been approved, according to its website.

Swiftmerge will continue to engage in due diligence efforts as it works towards signing a definitive agreement, but the SPAC will remain in SPACInsider‘s “Searching” column until that time.

 

Recent Posts
by Nicholas Alan Clayton on 2024-07-15 at 10:54am

Aquaron (NASDAQ:AQU) has entered into a definitive agreement to combine with hydrogen technology firm HUTURE at an initial equity value of about $1 billion. Shanghai-based HUTURE has developed technology for hydrogen fuel cell-powered heavy trucks and the refilling stations that would supply them. The combined company is expected to trade on the Nasdaq once the...

by Nicholas Alan Clayton on 2024-07-15 at 7:56am

At the SPAC of Dawn The third week of July is to kick off with AIB‘s (OTC:AIBAF) vote to complete its combination with PS International and may be joined by a pair of new SPAC IPOs while four other SPACs hold extension votes later in the week. Meanwhile, the biggest mover in SPAC world is...

by Kristi Marvin on 2024-07-13 at 11:44am

Terms Tracker for the Week Ending July 12, 2024 Welcome to our weekly column where we discuss the findings from our IPO terms tracker based on the previous week’s pricings. The rush is on to price the SPAC IPOs with anchor investors while they still can and Cantor managed to push out two of them...

by Nicholas Alan Clayton on 2024-07-12 at 8:17am

At the SPAC of Dawn With all eyes on the fireworks both literal and figurative in Western politics this month, July has hosted a relative drought of new business combinations with just one so far announced. But, there are flashes on the horizon as three SPACs signed letters of intent to combine with targets in...

by Nicholas Alan Clayton on 2024-07-11 at 4:59pm

Launch One Acquisition Corp. announced the pricing of its $200 million IPO and its units are expected to begin trading on the Nasdaq under the symbol “LPAAU”, Friday, July 12, 2024. The new SPAC aims to combine with an established company of scale in healthcare and healthcare-related industries and, in particular, life sciences, globally. Launch...

logo

Copyright © 2023 SPACInsider, Inc. All Rights Reserved